David Bullough

Biography

  David Bullough is a nonclinical consultant with over 25 years of pharmaceutical R & D experience specializing in the development of small molecules and emerging new therapeutic modalities in multiple therapeutic areas. He was most recently the Vice President of Preclinical Development at RaNA developing new approaches to treating rare genetic CNS disorders and an Executive Director at Pfizer in Cambridge, MA where he led multiple global therapeutic teams advancing metabolic disease candidates from discovery into early development. Dr. Bullough was formerly the Vice President of Preclinical Development at Metabasis in La Jolla, CA, where he was responsible for Nonclinical Safety, DMPK, Bioanalytical, and Pharmaceutical Development, and for leading teams developing novel drugs targeting the liver and liver pathways for the treatment of metabolic, antiviral, and oncology diseases. Prior to joining Metabasis, Dr. Bullough was with Gensia, where he managed Cardiovascular Pharmacology and led a number of major discovery and development projects. Dr. Bullough was a research faculty member at UCSD in La Jolla, CA and received his Ph.D. in Biochemistry from the University of Cambridge in the UK.

Research Interest